Importance of dehydroepiandrosterone and dehydroepiandrosterone sulfate in different diseases;A dehidroepiandroszteron és dehidroepiandroszteron-szulát jelentosége különbözo kórállapotokban

Orvosi Hetilap

Volumn 148, Issue 14, 2007, Pages 651-657

  Bácsi, Krisztián ^a,b   Kósa, János ^a   Lazáry, Áron ^a   Horváth, Henrik ^a   Balla, Bernadett ^a   Lakatos, Péter ^a   Speer, Gábor ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b NONE   (Hungary)

Author keywords

Dehydroepiandrosterone; Dehydroepiandrosterone sulfate; Intracrinology

Indexed keywords

ALCOHOL; AMINOGLUTETHIMIDE; AMLODIPINE; AMPICILLIN; ANDROGEN; BENFLUOREX; BROMOCRIPTINE; CARBAMAZEPINE; CITALOPRAM; CLOMIFENE; CLOMIPRAMINE; COLESTYRAMINE; DANAZOL; DEXAMETHASONE; DILTIAZEM; DOPAMINE; ESTROGEN; GESTAGEN; HALOPERIDOL; IMIPRAMINE; LITHIUM; METFORMIN; NICOTINE; PHENYTOIN; PRASTERONE; PRASTERONE SULFATE; PRAVASTATIN; RETINOL; TESTOSTERONE; UNINDEXED DRUG; SEX HORMONE;

ACNE; AGE DISTRIBUTION; AGING; ANDROGEN BLOOD LEVEL; ANDROGEN METABOLISM; ANDROGEN SYNTHESIS; AUTOIMMUNE DISEASE; BREAST CANCER; CARDIOVASCULAR DISEASE; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; ESTROGEN BLOOD LEVEL; GONAD FUNCTION; HIRSUTISM; HUMAN; MENTAL DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOPOROSIS; POSTMENOPAUSE OSTEOPOROSIS; PROSTATE CANCER; REVIEW; SEBORRHEA; SEXUAL DYSFUNCTION; STEROIDOGENESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; BIOSYNTHESIS; LIPID METABOLISM; METABOLISM;

ANDROGENS; CARDIOVASCULAR DISEASES; DEHYDROEPIANDROSTERONE; DEHYDROEPIANDROSTERONE SULFATE; DIABETES MELLITUS, TYPE 2; ESTROGENS; GONADAL STEROID HORMONES; HUMANS; LIPID METABOLISM; LUPUS ERYTHEMATOSUS, SYSTEMIC; METABOLIC NETWORKS AND PATHWAYS; OSTEOPOROSIS, POSTMENOPAUSAL; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 34347218955     PISSN: 00306002     EISSN: 17886120     Source Type: Journal    
DOI: 10.1556/OH.2007.27903     Document Type: Review

References (47)

1. Barrett-Connor, E., Ferrara, A.: Dehydroepiandrosterone, dehydroepiandrosterone sulfate, obesity, waist-hip ratio, and noninsulin-dependent diabetes in postmenopausal women: the Rancho Bernardo Study. J. Clin. Endocrinol. Metab., 1996, 774, 259-270.
2. Barrett-Connor, E., Khaw, K. T., Yen, S. S.: A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N. Engl. J. Med., 1986, 315, 1519-1524.
3. Benz, D. J., Haussler, M. R., Thomas, M. A. és mtsai: High-affinity androgen binding and androgenic regulation of alpha 1(I)-procollagen and transforming growth factor-beta steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology, 1991, 128, 2723-2730.
4. Bjornerem, A., Straume, B., Midtby, M. és mtsai: Endogenous sex hormones in relation to age, sex, lifestyle factors, and chronic diseases in a general population: The Tromso Study. J. Clin. Endocrinol. Metab., 2004, 89, 6039-6047.
5. Casson, P. R., Andersen, R. N., Gerrod, H. G. és mtsai: Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women. Am. J. Obstet. Gynecol., 1993, 169, 1536-1539.
6. Chang, D. M., Lan, J. L., Lin, H. Y. és mtsai: Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus - A multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum., 2002, 46, 2924-2927.
7. Cibula, D., Hill, M., Starka, L.: The best correlation of the new index of hyperandrogenism with the grade of increased body hair. Eur. J. Endocrinol, 2000, 143, 405-408.
8. Davis, S. R., Davison, S. L., Donath S. és mtsai: Circulating androgen levels and self-reported sexual function in women. JAMA, 2005, 294, 91-96.
9. de la Torre, B., Fransson, J., Scheynius, A.: Blood dehydroepiandrosterone sulphate (DHEAS) levels in pemphigoid/pemphigus and psoriasis. Clin. Exp. Rheumatol., 1995, 13, 345-348.
10. DeFazio, J., Meldrum, D. R., Winer, J. H. és mtsai: Direct action of androgen on hot flushes in the human male. Maturitas, 1984, 6, 3-8.
11. Diamond, R, Cusan, L., Gomez, J. L. és mtsai: Metabolic effects of 12-month percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J. Endocrinol., 1996, 150, 43-50.
12. Eller, N. H., Netterstrom, B., Allerup, P.: Progression in intima media thickness - the significance of hormonal biomarkers of chronic stress. Psychoneuroendocrinology, 2005, 30, 715-723.
13. Ferrando, S. J., Rabkin, J. G., Poretsky, L.: Dehydroepiandrosterone sulfate (DHEAS) and testosterone: Relation to HIV illness stage and progression over one year. J. Acquir. Immune Defic. Syndr., 1999, 22, 146-154.
14. Haffner, S. M., Moss, S. E., Klein, B. E. és mtsai: Sex hormones and DHEA-SO4 in relation to ischemic heart disease mortality in diabetic subjects. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. Diabetes Care, 1996, 19, 1045-1050.
15. Hartkamp, A., Geenen, R., Godaert, G. L. és mtsai: The effect of dehydroepiandrosterone on lumbar spine bone mineral density in patients with quiescent systemic lupus erythematosus. Arthritis Rheum., 2004, 50, 3591-3595.
16. Imrich, R., Rovensky, J., Malis, F. és mtsai: Low levels of dehydroepiandrosterone sulphate in plasma, and reduced sympathoadrenal response to hypoglycaemia in premenopausal women with rheumatoid arthritis. Ann. Rheum. Dis., 2005, 64, 202-206.
17. Johannsson, G., Burman, R, Wiren, L. és mtsai: Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: A placebo-controlled trial. J. Clin. Endocrinol. Metab., 2002, 87, 2046-2052.
18. Kameda, W, Daimon, M., Oizumi, T. és mtsai: Association of decrease in serum dehydroepiandrosterone sulfate levels with the progression to type 2 diabetes in men of a Japanese population: The Funagata Study. Metab. Clin. Exp., 2005, 54, 669-676.
19. Labrie, F., Belanger, A., Cusan, L. és mtsai: Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J. Clin. Endocrinol. Metab.,1997, 82, 2396-2402.
20. Labrie, F., Diamond, P., Cusan, L. és mtsai: Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina, and endometrium in postmenopausal women. J. Clin. Endocrinol. Metab., 1997, 82, 3498-3505.
21. Leowattana, W.: DHEAS as a new diagnostic tool. Clin. Chim. Acta, 2004, 341, 1-15.
22. Maccario, M., Mazza, E., Ramunni, J. és mtsai: Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women. Clin. Endocrinol., 1999, 50, 595-600.
23. Majewska, M. D.: Neuronal actions of dehydroepiandrosterone. possible roles in brain development, aging, memory, and affect. Ann. N. Y. Acad. Sci., 1995, 774, 111-120.
24. Mazat, L., Lafont, S., Berr, C. és mtsai: Prospective measurements of dehydroepiandrosterone sulfate in a cohort of elderly subjects: Relationship to gender, subjective health, smoking habits, and 10-year mortality. Proc. Natl. Acad. Sci., 2001, 98, 8145-8150.
25. Moriyama, Y., Yasue, H., Yoshimura, M. és mtsai: The plasma levels of dehydroepiandrosterone sulfate are decreased in patients with chronic heart failure in proportion to the severity. J. Clin. Endocrinol. Metab., 2000, 85, 1834-1840.
26. Okamoto, K.: Relationship between dehydroepiandrosterone sulfate and serum lipid levels in japanese men. J. Epidemiol., 1996, 6, 63-67.
27. Pitts, R. L.: Serum elevation of dehydroepiandrosterone sulfate associated with male pattern baldness in young men. J. Am. Acad. Dermatol., 1987, 16, 571-573.
28. Ponjee, G. A., De Rooy, H. A., Vader, H. L.: Androgen turnover during marathon running. Med. Sci. Sports. Exerc., 1994, 26, 1274-1277.
29. Rainey, W, E., Carr, B. R., Sasano, H. és mtsai: Dissecting human adrenal androgen production. Trends Endocrinol. Metab., 2002, 13, 234-239.
30. Ramsaransing, G. S., Heersema, D. J., De Keyser, J.: Serum uric acid, dehydroepiandrosterone sulphate, and apolipoprotein E genotype in benign vs. progressive multiple sclerosis. Eur. J. Neurol., 2005, 12, 514-518.
31. Reiter, W. J., Pycha, A., Schatzl G. és mtsai: Serum dehydroepiandrosterone sulfate concentrations in men with erectile dysfunction. Urology, 2000, 55, 755-758.
32. Reiter, W. J., Pycha, A., Schatzl, G. és mtsai: Dehydroepiandrosterone in the treatment of erectile dysfunction: A prospective, double-blind, randomized, placebo-controlled study. Urology, 1999, 53, 590-594.
33. Slayden, S. M., Moran, C., Sams, W. M. és mtsai: Hyperandrogenemia in patients presenting with acne. Fertil. Steril., 2001, 75, 889-892.
34. Smit, P., van Schaik, R. H., van der Werf, M. és mtsai: A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels. J. Clin. Endocrinol. Metab., 2005, 90, 5313-5316.
35. Spark, R. F.: Dehydroepiandrosterone: A springboard hormone for female sexuality. Fertil. Steril., 2002, 77, 19-25.
36. Spivak, B., Maayan R., Kotler M. és mtsai: Elevated circulatory level of GABA(A)-antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder. Psychol. Med., 2000, 30, 1227-1231.
37. Stomati, M., Monteleone, P., Casarosa, E. és mtsai: Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause. Gynecol. Endocrinol., 2000, 14, 342-363.
38. Strauh, R. H., Vogl, D., Gross, V. és mtsai: Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease. Am. J. Gastroenterol., 1998, 93, 2197-2202.
39. Strauh, R. H., Weidler, C., Demmel, B. és mtsai: Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus. Ann. Rheum. Dis., 2004, 63, 961-968.
40. Thiboutot, D., Gilliland, K., Light, J. és mtsai: Androgen metabolism in sebaceous glands from subjects with and without acne. Arch. Dermatol., 1999, 135, 1041-1045.
41. Thijs, L., Fagard, R., Forette, F. és mtsai: Are low dehydroepiandrosterone sulphate levels predictive for cardiovascular diseases? A review of prospective and retrospective studies. Acta Cardiol., 2003, 58, 403-410.
42. Tok, E. C., Ertunc, D., Oz, U. és mtsai: The effect of circulating androgens on bone mineral density in postmenopausal women. Maturitas, 2004, 48, 235-242.
43. Toth M., Racz K., Varga I. és mtsai: Plasma dehydroepiandrosterone sulfate levels in patients with hyperfunctioning and non-hyperfunctioning adrenal tumors before and after adrenal surgery. Eur. J. Endocrinol., 1997, 136, 290-295.
44. Vermeulen, A., Suy, E., Rubens, R.: Effect of prolactin on plasma DHEA (s) levels. J. Clin. Endocrinol. Metab., 1977, 44, 1222-1225.
45. Villareal, D. T., Holloszy, J. O.: Effect of DHEA on abdominal fat and insulin action in elderly women and men - A randomized controlled trial. J. Am. Med. Assoc., 2004, 292, 2243-2248.
46. Villareal, D. T., Holloszy, J. O., Kohrt, W. M.: Effects of DHEA replacement on bone mineral density and body composition in elderly women and men. Clin. Endocrinol., 2000, 53, 561-568.
47. Wierman, E. M., Basson, R., Davis, S. R. és mtsai: Androgen therapy in women: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab., 2006, 91, 3697-3710.